Only those opting for advanced levels will take the additional paper. In a major shift aimed at strengthening analytical learning, the Central Board of Secondary Education (CBSE) has introduced a ...
Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results